Let’s break the stigma of Vitiligo together. Help us discover potential treatments for Vitiligo by enrolling in our Vitiligo clinical trials.
Let’s Overcome
Vitiligo
Vitiligo causes white patches or depigmentation of the skin; it is the most common form of vitiligo. It affects around 0.5% – 2% of the population globally. Vitiligo can occur at any age and affects people of all races and ethnicities. Currently limited Vitiligo treatment options include topical steroids, vitamin D3, calcineurin inhibitors, topical immunomodulators, phototherapy, surgical treatments, and camouflage. MetroBoston is conducting clinical trials in vitiligo to determine the safety and efficacy of new potential treatments that may improve skin pigmentation.
Enroll Now
Safety, efficacy, and Tolerability Evaluation
Eligibility Criteria
Enroll in our Vitiligo clinical trials near you in Boston and help us untether the complications of Vitiligo.
Age
10-19 Years & Above
Gender
Male and Female
Current Status
Recruiting
Total Studies
01
Location
Brighton – Boston
Frequently Asked Questions
What is Vitiligo?
Vitiligo is a long-term skin condition characterized by the loss of pigment-producing cells, resulting in the development of white patches or depigmentation on various parts of the body.
What causes Vitiligo?
The exact cause of vitiligo is not fully understood, but it is believed to involve a combination of genetic, autoimmune, and environmental factors.
What is the cure for Vitiligo?
There is no known cure for Vitiligo. However, MetroBoston is conducting Vitiligo Clinical Trials to find possible treatments for the condition.
What are the complications of Vitiligo?
Some of the complications accompanying Vitiligo may be skin sensitivity to the sun, effects on mental health, or autoimmune disorders.
Am I at an increased risk of skin cancer due to Vitiligo?
Individuals with vitiligo generally have a lower risk of developing skin cancer in the areas affected by depigmentation. Melanocytes are reduced or absent in vitiligo-affected skin patches. As a result, these areas are less likely to develop melanoma, a type of skin cancer originating from melanocytes.
617-789-5300